Pneumococcal conjugate second or third-dose vaccines (PCVc) in Belgium
Belgium: Pneumococcal conjugate second or third-dose vaccines (PCVc) was 94.0% in 2025. ◆ Volatile
Latest (2025)
94.0%
Change on year
unchanged
World rank
46th
of 194 countries
All-time high
94.0%
in 2015
All-time low
0.0%
in 2008
Years of data
18
2008–2025
Pneumococcal conjugate second or third-dose vaccines (PCVc) in Belgium, 2008–2025
Source: World Health Organization, Global Health Observatory.
Analysis
In 2025, pneumococcal conjugate second or third-dose vaccines (pcvc) in Belgium stood at 94.0%. That is the highest value across all 18 years on record.
That represents a change of unchanged over ten years.
Over the whole period, pneumococcal conjugate second or third-dose vaccines (pcvc) in Belgium peaked at 94.0% in 2015 and was at its lowest, 0.0%, in 2008.
Belgium ranks 46th of 194 countries on this measure, in the top quarter.
The series is highly variable year to year, so single readings are best treated with caution.
Pneumococcal conjugate second or third-dose vaccines (PCVc) in Belgium, year by year
| Year | Value | Change |
|---|---|---|
| 2008 | 0.0% | — |
| 2009 | 0.0% | — |
| 2010 | 0.0% | — |
| 2011 | 0.0% | — |
| 2012 | 93.0% | — |
| 2013 | 93.0% | +0.0% |
| 2014 | 93.0% | +0.0% |
| 2015 | 94.0% | +1.1% |
| 2016 | 94.0% | +0.0% |
| 2017 | 94.0% | +0.0% |
| 2018 | 94.0% | +0.0% |
| 2019 | 94.0% | +0.0% |
| 2020 | 94.0% | +0.0% |
| 2021 | 94.0% | +0.0% |
| 2022 | 94.0% | +0.0% |
| 2023 | 94.0% | +0.0% |
| 2024 | 94.0% | +0.0% |
| 2025 | 94.0% | +0.0% |
Belgium compared with similar countries
- Belgium's 94.0% is above the median for high income countries, which is 91.0%, 1.0× the median. (63 countries reporting)
- Belgium's 94.0% is above the median for Europe & Central Asia, which is 87.0%, 1.1× the median. (51 countries reporting)
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2000s | 0.0% | 0.0% | 0.0% | 2 |
| 2010s | 74.9% | 0.0% | 94.0% | 10 |
| 2020s | 94.0% | 94.0% | 94.0% | 6 |
Countries ranked near Belgium
More health data for Belgium
- Un projection of annual infant deaths, annual growth rate -3.28 % change on previous year (2100)
- Heat deaths vs projected death rates, annual growth rate -0.2923 % change on previous year (2090)
- Estimated changes in temperature-related death rates compared to projected death rates 1,160 deaths per 1,000 people (2090)
- Number of infants who die before age 1 59 deaths (2100)
- Neonatal tetanus - number of reported cases, gaps filled 0 (2025)
- Population ages 00-04, female, annual growth rate -2.11 % change on previous year (2025)
- Population ages 00-04, female, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 00-04, female, per capita 0.0229 units per person (2025)
- Population ages 00-04, male, annual growth rate -1.96 % change on previous year (2025)
- Population ages 00-04, male, per unit of GDP 0 units per US$ of GDP (2025)
Frequently asked questions
- What is pneumococcal conjugate second or third-dose vaccines (pcvc) in Belgium?
- Pneumococcal conjugate second or third-dose vaccines (pcvc) in Belgium was 94.0% in 2025, according to World Health Organization, Global Health Observatory.
- What is the highest pneumococcal conjugate second or third-dose vaccines (pcvc) recorded in Belgium?
- The highest recorded value was 94.0% in 2015.
- What is the lowest pneumococcal conjugate second or third-dose vaccines (pcvc) recorded in Belgium?
- The lowest recorded value was 0.0% in 2008.
- How does Belgium rank for pneumococcal conjugate second or third-dose vaccines (pcvc)?
- Belgium ranks 46th out of 194 countries with data for 2025.
- Is pneumococcal conjugate second or third-dose vaccines (pcvc) rising or falling in Belgium?
- Over the last ten years it is unchanged. The long-run trend across the full record is volatile.
- Where does this Belgium data come from?
- The figures come from World Health Organization, Global Health Observatory, published as part of Pneumococcal conjugate second or third-dose vaccines (PCVc) immunization coverage by the locally recommended age (%) (WUENIC). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 18 observations, free to reuse under CC BY-NC-SA 3.0 IGO (WHO).